Neeraj Narula

7.3k citations

192 papers · 4.5k indexed · 2 hit papers · h-index 32

Impact in

Genetics top 0.2%
- Inflammatory Bowel Disease
Gastroenterology top 1%

Papers in

Genetics 161
- Inflammatory Bowel Disease 159
Epidemiology 143
- Microscopic Colitis 129
- Autoimmune and Inflammatory Disorders 20

Co-authors: Jean‐Frédéric Colombel John K. Marshall Bruce E. Sands Shailja C. Shah Giulia Roda Bindia Jharap Jean–Frédéric Colombel Laurent Peyrin‐Biroulet
Journals: Journal of Crohn s and Colitis (39 papers)Inflammatory Bowel Diseases (27 papers)The American Journal of Gastroenterology (20 papers)Alimentary Pharmacology & Therapeutics (15 papers)Clinical Gastroenterology and Hepatology (14 papers)
Partner nations: Canada United States Austria

In The Last Decade

Neeraj Narula

176 papers receiving 4.5k citations

Hit Papers

align trajectories log scale

Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis 2023 · 67 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Clinical Gastroenterology and Hepatology
2016 Clinical and Translational Gastroenterology

Peers

Countries citing papers authored by Neeraj Narula

Since Specialization

Citations

This map shows the geographic impact of Neeraj Narula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeraj Narula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeraj Narula more than expected).

Fields of papers citing papers by Neeraj Narula

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neeraj Narula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeraj Narula. The network helps show where Neeraj Narula may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Neeraj Narula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Neeraj Narula Line = papers co-authored together Neeraj Narula links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	P0595 Comparative effectiveness between ustekinumab and vedolizumab after anti-TNF failure in Ulcerative Colitis: Real-world experience Journal of Crohn s and Colitis ·Melita Štruc, Sébastien Faure, Yanadade Pakawatthapana, 聡牛丸, Virginia Solitano, Gerard Nobel, Yukio Amenomori, Shuai Yuan, Gary Wild, Péter L. Lakatos, Neeraj Narula, Vipul Jairath, Talat Bessissow	2025	0
2	Impact of diet on inflammatory bowel disease risk: systematic review, meta-analyses and implications for prevention EClinicalMedicine ·Antoine Meyer, Manasi Agrawal, Kang HyuHyun, Emily C L Wong, Josiah Taylor, Kriangsak Rukpukdee, Neeraj Narula, Jean‐Frédéric Colombel, Franck Carbonnel	2025	1
3	Meta‐Analysis: Improvement of Bowel Urgency With Advanced Therapies for Inflammatory Bowel Disease Alimentary Pharmacology & Therapeutics ·Ragaa Aly Abd El-Aty, Hannah Landry, Jan Mikolášek, Yuhong Yuan, Neeraj Narula, Christopher Ma, Maria Cino, Alexa N. Sasson, Vipul Jairath, Parul Tandon	2025	1
4	A Review of the Modified Multiplier of Simple Endoscopic Score for Crohn's Disease and How to Use It in Clinical Trials and Practice The American Journal of Gastroenterology ·Petter Granlund, Anjali Wilcox, Emily C L Wong, Parambir S. Dulai, John K. Marshall, Walter Reinisch, Neeraj Narula	2025	0
5	Comparative Predictive Utility of MM-SES-CD and SES-CD for Week 52 Endoscopic Remission in the Ileum and Colon in Crohn’s Disease Inflammatory Bowel Diseases ·Emily C L Wong, Parambir S. Dulai, John K. Marshall, А.А. Шаститко, Walter Reinisch, Neeraj Narula	2025	0
6	Perspectives on the sustained engagement with digital health tools: protocol for a qualitative interview study among people living with Inflammatory Bowel Disease or irritable bowel syndrome BMJ Open ·E. ABDEL KAREEM, Anna McMullan, E. Grossmayer, RV Haning, 寛小方, Viji Narayana, Adrijana D’Silva, Lesley A. Graff, Neeraj Narula, David M. Rodrigues, Aida Fernandes, Deborah A. Marshall, Paul Moayyedi, Justin Presseau	2024	1
7	Screen Failures and Causes in Inflammatory Bowel Disease Randomized Controlled Trials: A Study of 16 913 Screened Patients Inflammatory Bowel Diseases ·Mathieu Uzzan, Debebe Hailegebriel, Laurent Peyrin‐Biroulet, Yoram Bouhnik, Neeraj Narula, Vipul Jairath, Ryan C. Ungaro, Johan Burisch, Julien Kirchgesner, Я.Х. Бицин, 以諾康, Walter Reinisch	2024	2
8	Use of Modified Multiplier of the Simple Endoscopic Score for Crohn’s Disease Endoscopic Improvement Thresholds Enhances Effect Size Differentiation Between Adalimumab Versus Placebo: A Post Hoc Analysis of the EXTEND Trial Journal of Crohn s and Colitis ·Emily C L Wong, Parambir S. Dulai, John K. Marshall, Abigail Egid, Vipul Jairath, Walter Reinisch, Neeraj Narula	2024	2
9	P409 Optimal endoscopic healing thresholds defined by MM-SES-CD < 22.5 and SES-CD < 4 are associated with low risk of disease progression in Crohn’s disease Journal of Crohn s and Colitis ·Neeraj Narula, Emily C L Wong, Parambir S. Dulai, Jyoti C. Patel, John K. Marshall, Clara Yzet, Vipul Jairath, Ryan C. Ungaro, Jean‐Frédéric Colombel, Walter Reinisch, (unknown)	2024	1
10	P716 Efficacy and safety of upadacitinib during induction in Crohn’s disease: Real-world experience Journal of Crohn s and Colitis ·Melita Štruc, Sébastien Faure, 聡牛丸, Waqqas Afif, Alain Bitton, Gary Wild, Neeraj Narula, Péter L. Lakatos, Talat Bessissow	2024	1
11	Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study Digestive and Liver Disease ·Talat Bessissow, Neeraj Narula, Christopher Ma, Thatiany Rodrigues Mendes, María Eberg, Edmund Schulz, Vipul Jairath	2023	3
12	Pharmacological Therapies for the Management of Fistulizing Crohn’s Disease: A Systematic Review and Meta-Analysis Journal of Crohn s and Colitis ·Sudheer K. Vuyyuru, Virginia Solitano, Neeraj Narula, Matthew J. Lee, John K MacDonald, Jeffrey D. McCurdy, Siddharth Singh, Christopher Ma, Vipul Jairath	2023	11
13	Placebo Response Rates in Randomized Controlled Trials for Perianal Crohn’s Disease: A Systematic Review and Meta-Analysis Journal of Crohn s and Colitis ·이희철, Christopher Ma, Rocío Sedaño, Jurij Hanžel, Cassandra McDonald, Malcolm Hogan, Gursimran Kochhar, Neeraj Narula, Laurent Peyrin‐Biroulet, Silvio Danese, John K MacDonald, Vipul Jairath	2022	2
14	Increased Expression of Interleukin-13 Receptor in Ileum Associated With Nonresponse to Adalimumab in Ileal Crohn’s Disease Inflammatory Bowel Diseases ·Emily C L Wong, Curtis Mb, Alexandra Richards, Parambir S. Dulai, Jean‐Frédéric Colombel, John K. Marshall, Walter Reinisch, Neeraj Narula	2022	2
15	Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease The American Journal of Gastroenterology ·Neeraj Narula, Emily C L Wong, Parambir S. Dulai, John K. Marshall, Vipul Jairath, Walter Reinisch	2022	40
16	The Performance of the Rutgeerts Score, SES-CD, and MM-SES-CD for Prediction of Postoperative Clinical Recurrence in Crohn’s Disease Inflammatory Bowel Diseases ·Neeraj Narula, Emily C L Wong, Parambir S. Dulai, John K. Marshall, Vipul Jairath, Walter Reinisch	2022	8
17	Does a High-inflammatory Diet Increase the Risk of Inflammatory Bowel Disease? Results From the Prospective Urban Rural Epidemiology (PURE) Study: A Prospective Cohort Study Gastroenterology ·Neeraj Narula, Emily C L Wong, Mahshid Dehghan, John K. Marshall, Paul Moayyedi, Salim Yusuf	2021	16
18	Enteral nutritional therapy for induction of remission in Crohn's disease Cochrane Database of Systematic Reviews ·Neeraj Narula, Amit Dhillon, Dongni Zhang, Mary Sherlock, Mélody Tondeur, Mary Zachos	2018	214
19	Systematic review: safety of mesalazine in ulcerative colitis Alimentary Pharmacology & Therapeutics ·Priya Sehgal, Jean‐Frédéric Colombel, Aiya Aboubakr, Neeraj Narula	2018	125
20	Meta‐analysis: peri‐operative anti‐ TNF α treatment and post‐operative complications in patients with inflammatory bowel disease Alimentary Pharmacology & Therapeutics ·Neeraj Narula, Naijie Qi, John K. Marshall	2013	113

About Neeraj Narula

Neeraj Narula is a scholar working on Genetics, Epidemiology, Gastroenterology, Surgery and Hepatology, having authored 192 papers that have together received 4.5k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (159 papers), Microscopic Colitis (129 papers), Eosinophilic Esophagitis (38 papers), Autoimmune and Inflammatory Disorders (20 papers), Helicobacter pylori-related gastroenterology studies (20 papers), Liver Diseases and Immunity (10 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Diverticular Disease and Complications (9 papers). The work is most often cited by research in Genetics (3.2k citations), Gastroenterology (455 citations), Epidemiology (2.5k citations), Surgery (1.6k citations) and Immunology (740 citations). Neeraj Narula has collaborated with scholars based in Canada, United States and Austria. Frequent co-authors include Jean‐Frédéric Colombel, John K. Marshall, Bruce E. Sands, Shailja C. Shah, Giulia Roda, Bindia Jharap, Jean–Frédéric Colombel, Laurent Peyrin‐Biroulet, Emily C L Wong and Parambir S. Dulai. Their work appears in journals such as Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, The American Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact